Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 24 04:00PM ET
367.07
Dollar change
+6.05
Percentage change
1.68
%
Index- P/E- EPS (ttm)-5.17 Insider Own0.71% Shs Outstand59.19M Perf Week0.34%
Market Cap21.81B Forward P/E116.13 EPS next Y3.16 Insider Trans0.00% Shs Float59.01M Perf Month-0.42%
Income-295.51M PEG- EPS next Q-0.89 Inst Own56.75% Short Float2.48% Perf Quarter-10.55%
Sales1.23B P/S17.76 EPS this Y51.16% Inst Trans-7.08% Short Ratio5.35 Perf Half Y-25.39%
Book/sh69.22 P/B5.30 EPS next Y225.42% ROA-7.70% Short Interest1.46M Perf Year-8.95%
Cash/sh53.51 P/C6.86 EPS next 5Y- ROE-8.55% 52W Range327.73 - 550.76 Perf YTD-3.51%
Dividend Est.- P/FCF- EPS past 5Y-17.05% ROI-7.18% 52W High-33.35% Beta0.64
Dividend TTM- Quick Ratio9.01 Sales past 5Y287.78% Gross Margin81.59% 52W Low12.01% ATR (14)11.43
Dividend Ex-Date- Current Ratio9.75 EPS Y/Y TTM60.46% Oper. Margin-37.75% RSI (14)46.56 Volatility2.22% 3.18%
Employees1148 Debt/Eq0.00 Sales Y/Y TTM198.89% Profit Margin-24.06% Recom1.61 Target Price466.71
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q10.02% Payout- Rel Volume0.60 Prev Close361.02
Sales Surprise2.02% EPS Surprise-34.80% Sales Q/Q82.26% EarningsMay 09 BMO Avg Volume273.29K Price367.07
SMA20-2.14% SMA50-2.97% SMA200-15.06% Trades Volume164,614 Change1.68%
Date Action Analyst Rating Change Price Target Change
Feb-15-24Initiated Wolfe Research Peer Perform
Dec-20-23Downgrade William Blair Outperform → Mkt Perform
Dec-20-23Downgrade Deutsche Bank Buy → Hold
Jul-31-23Initiated Scotiabank Sector Perform $516
Jul-24-23Downgrade UBS Buy → Neutral $480 → $570
Jul-17-23Resumed Evercore ISI Outperform $436
Jun-15-23Initiated Societe Generale Sell
May-31-23Initiated UBS Buy $480
Apr-25-23Initiated Citigroup Buy $450
Mar-14-23Upgrade Robert W. Baird Neutral → Outperform $460
May-14-24 06:43PM
May-13-24 10:30AM
May-10-24 04:25PM
May-09-24 12:28PM
06:52AM
01:00AM Loading…
01:00AM
May-08-24 10:56AM
May-07-24 05:30PM
01:00AM
May-02-24 06:42PM
01:00AM
Apr-16-24 01:00AM
Mar-29-24 04:42AM
Mar-27-24 02:00AM
Mar-26-24 04:00PM
02:00AM Loading…
02:00AM
Mar-22-24 10:28AM
07:47AM
Mar-21-24 04:45PM
Mar-20-24 06:38PM
Mar-19-24 07:16AM
Mar-17-24 08:49AM
Mar-07-24 04:01PM
08:14AM
07:28AM
Mar-01-24 10:12AM
Feb-29-24 10:16PM
01:00AM
Feb-28-24 08:38AM
Feb-26-24 01:00AM
08:00AM Loading…
Feb-22-24 08:00AM
01:00AM
Feb-21-24 10:08PM
Feb-20-24 01:00AM
Jan-22-24 05:35AM
Jan-18-24 01:00AM
Jan-12-24 08:30AM
Jan-08-24 01:00AM
Jan-04-24 06:44PM
Jan-02-24 01:00AM
Dec-22-23 05:05AM
Dec-21-23 04:09PM
09:50AM
Dec-20-23 04:33PM
04:02PM
03:20PM
12:15PM
07:26AM
06:30AM
01:00AM
Dec-18-23 03:17AM
Dec-12-23 03:04PM
Dec-08-23 05:19AM
Dec-03-23 05:25AM
Dec-01-23 06:55AM
Nov-28-23 06:59PM
04:04PM
12:06PM
08:51AM
05:17AM
01:00AM
Nov-16-23 07:40AM
Nov-07-23 11:22AM
09:04AM
Nov-06-23 01:16PM
Nov-05-23 05:54PM
Nov-01-23 10:57PM
10:15AM
02:00AM
02:00AM
Oct-31-23 05:05PM
04:05PM
09:14AM
02:00AM
Oct-24-23 01:00AM
Oct-20-23 03:24AM
Oct-05-23 08:13AM
Sep-27-23 04:09PM
04:06PM
12:25PM
Sep-26-23 04:13PM
10:01AM
Sep-21-23 01:00AM
Sep-17-23 09:50AM
Sep-16-23 09:00AM
09:00AM
Sep-15-23 04:27PM
01:00AM
Aug-30-23 01:00AM
Aug-21-23 01:44AM
Aug-19-23 11:02AM
Aug-09-23 12:19PM
Jul-31-23 10:00AM
09:51AM
Jul-28-23 10:59AM
Jul-27-23 04:12PM
08:29AM
01:00AM
Jul-26-23 04:07PM
Jul-24-23 04:30PM
argenx SE is a global immunology company, which engages in improving the lives of people suffering from severe autoimmune diseases. It operates through the following geographical segments: United States, Japan, EMEA, and China. The company was founded by Hans J. W. de Haard, Torsten Dreier, and Tim van Hauwermeiren in 2008 and is headquartered in Amsterdam, the Netherlands.